International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 3 | Views: 160 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Review Papers | Radiology and Medical Imaging Sciences | Bulgaria | Volume 12 Issue 4, April 2023 | Popularity: 5.1 / 10


     

Hereditary Hemorrhagic Telangiectasia: Recognizing, Screening and Treating from a Neurological Point of View

Vladev G., Sirakova K.


Abstract: The Osler-Weber-Rendu condition, also known as hereditary hemorrhagic telangiectasia (HHT), is a rare genetic disorder affecting various areas of the human body. Two prevalent genotypes involve mutations in the endoglin gene (HHT-type 1) and the ALK-1 gene (HHT-type 2). These genetic alterations result in abnormal blood vessels, such as arteriovenous malformations (AVMs) in the liver, lungs, and brain (1) . Patients frequently experience continuous nosebleeds and gastrointestinal bleeding, leading to iron deficiency anemia. Liver and lung AVMs can lead to various clinical presentations, including portal hypertension, encephalopathy, and high-output cardiac failure in the liver, and shortness of breath, respiratory distress, and stroke events in the lungs (2). The prevalence of brain AVMs in HHT patients ranges from 10-20% (3, 4) , more frequently linked to the HHT-type 1 genotype. Symptoms include headaches, seizures, and intracranial hemorrhage (ICH). Identifying affected patients can aid in family-wide screening, resulting in improved diagnostics and patient outcomes. Neurointerventionalists play a crucial role in diagnosing and treating cerebral vascular malformations, with most of the brain AVMs being categorized as Spetzler-Martin grades I-II (5) . A comprehensive physical examination, can lead to the observation of several HHT symptoms in such patients, leading to an Osler-Weber-Rendu disease clinical diagnosis. All patients should undergo diagnostic MRI or CT scans, which would verify the presence of a brain AVMs, and subsequently be discussed for endovascular therapy.


Keywords: Hereditary hemorrhagic telangiectasia, embolization


Edition: Volume 12 Issue 4, April 2023


Pages: 1136 - 1139


DOI: https://www.doi.org/10.21275/SR23418145420



Make Sure to Disable the Pop-Up Blocker of Web Browser




Text copied to Clipboard!
Vladev G., Sirakova K., "Hereditary Hemorrhagic Telangiectasia: Recognizing, Screening and Treating from a Neurological Point of View", International Journal of Science and Research (IJSR), Volume 12 Issue 4, April 2023, pp. 1136-1139, URL: https://www.ijsr.net/getabstract.php?paperid=SR23418145420, DOI: https://www.doi.org/10.21275/SR23418145420



Top